* Apollo Medical Holdings Inc AMEH.OQ AMEH.O is expected
to show a rise in quarterly revenue when it reports results
* The Alhambra California-based company is expected to
report a
10.4% increase in revenue to $350.1 million from $317 million a
year ago, according to the mean estimate from 4 analysts, based
on LSEG data.
* Refinitiv's mean analyst estimate for Apollo Medical
Holdings
Inc is for earnings of 33 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Apollo
Medical
Holdings Inc is $45, above its last closing price of $31.97.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Jun. 30 2023 0.25 0.25 0.28 Beat 12
Mar. 31 2023 0.31 0.31 0.31 Met 1.1
Dec. 31 2022 -0.11 -0.09 -0.06 Beat 33.3
Sep. 30 2022 0.31 0.32 0.56 Beat 75.8
Jun. 0.20 0.20 0.25 Beat 23.2
30 2022
Mar. 31 2022 0.32 0.32 0.31 Missed -3.1
Dec. 31 2021 0.26 0.27 0.30 Beat 13.2
Sep. 30 2021 0.34 0.34 0.69 Beat 102.9
This summary was machine generated November 4 at 03:05 GMT. All
figures in US dollars unless otherwise stated